| 7879875 |
P38 kinase inhibiting agents |
Meng-Hsin Chen, Robert Tynebor, Swaminathan Natarajan, Zhen Li, Soumya P. Sahoo |
2011-02-01 |
$44,131,000 |
| 7576122 |
Ophthalmic compositions for treating ocular hypertension |
Dong-Ming Shen |
2009-08-18 |
$54,880,000 |
| 7563816 |
Ophthalmic compositions for treating ocular hypertension |
Dong-Ming Shen |
2009-07-21 |
$97,142,000 |
| 7547720 |
Ophthalmic compositions for treating ocular hypertension |
Meng-Hsin Chen, Luping Liu, Swaminathan Natarajan, Robert Tynebor |
2009-06-16 |
$254,806,000 |
| 7528163 |
Ophthalmic compositions for treating ocular hypertension |
Meng-Hsin Chen, Luping Liu, Swaminathan Natarajan, Dong-Ming Shen, Robert Tynebor |
2009-05-05 |
$95,355,000 |
| 7494983 |
Ophthalmic compositions for treating ocular hypertension |
Meng-Hsin Chen, Luping Liu, Swaminathan Natarajan, Robert Tynebor |
2009-02-24 |
$90,933,000 |
| 7482345 |
P38 kinase inhibiting agents |
Meng-Hsin Chen, Robert Tynebor |
2009-01-27 |
|
| 7410992 |
Ophthalmic compositions for treating ocular hypertension |
Meng-Hsin Chen, Luping Liu, Swaminathan Natarajan, Robert Tynebor |
2008-08-12 |
$60,980,000 |
| 7314873 |
(Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
Swaminathan Natarajan, John E. Stelmach |
2008-01-01 |
|
| 7196082 |
Ophthalmic compositions for treating ocular hypertension |
Meng-Hsin Chen, Luping Liu, Swaminathan Natarajan, Robert Tynebor |
2007-03-27 |
$59,169,000 |
| 7196095 |
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds |
Tesfaye Biftu, Richard Thomas Beresis, Richard Berger, Steven L. Colletti, Dennis D. Feng +7 more |
2007-03-27 |
$59,169,000 |
| 6809199 |
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
John E. Stelmach, Meng-Hsin Chen, Luping Liu, Julianne A. Hunt, Rowena D. Ruzck +9 more |
2004-10-26 |
$135,161,000 |
| 5952321 |
Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Conrad P. Dorn, Philippe L. Durette, Paul E. Finke, Malcolm MacCoss, Sander G. Mills +4 more |
1999-09-14 |
$82,986,000 |
| 5747485 |
Substituted azetidiones as anti-inflammatory and antidegenerative agents |
Conrad P. Dorn, Philippe L. Durette, Paul E. Finke, Malcolm MacCoss, Sander G. Mills +5 more |
1998-05-05 |
$62,309,000 |
| 5591737 |
Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Conrad P. Dorn, Philippe L. Durette, Paul E. Finke, Malcolm MacCoss, Sander G. Mills +5 more |
1997-01-07 |
$227,680,000 |
| 5364848 |
Substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents |
Raymond A. Firestone, Paul E. Finke, William K. Hagmann, Shrenik K. Shah, Kevan R. Thompson |
1994-11-15 |
$78,565,000 |
| 5348953 |
Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Paul E. Finke, William K. Hagmann, Amy L. Kissinger, Malcolm MacCoss, Shrenik K. Shah |
1994-09-20 |
$29,209,000 |
| 5229381 |
Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Conrad P. Dorn, Paul E. Finke, William K. Hagmann, Malcolm MacCoss, Shrenik K. Shah |
1993-07-20 |
$28,658,000 |
| 5132301 |
Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents |
Raymond A. Firestone, Paul E. Finke, William K. Hagmann, Shrenik K. Shah, Kevan R. Thompson |
1992-07-21 |
$25,309,000 |
| 4891370 |
Cephalosporin derivatives as anti-inflammatory agents |
Morris Zimmerman, Bunnie M. Ashe |
1990-01-02 |
$113,976,000 |
| 4847247 |
Penicillin derivatives as anti-inflammatory and antidegenerative agents |
Kevan R. Thompson, Paul E. Finke |
1989-07-11 |
$7,137,000 |
| 4845088 |
Tetrazolyl derivatives of beta-lactams useful as elastase inhibitors |
William K. Hagmann, Paul E. Finke, Shrenik K. Shah |
1989-07-04 |
|
| 4797396 |
.beta.-Lactam derivatives as anti-inflammatory and antidegenerative agents |
Paul E. Finke, Morris Zimmerman, Bonnie M. Ashe, Conrad P. Dorn |
1989-01-10 |
$16,899,000 |
| 4717722 |
Substituted 1-oxa-dethiacephalosporins as anti-inflammatory and antidegenerative agents |
William K. Hagmann |
1988-01-05 |
$18,654,000 |
| 4711886 |
.beta.-lactam derivatives as anti-inflammatory and antidegenerative agents |
Paul E. Finke, Morris Zimmerman, Bonnie M. Ashe, Conrad P. Dorn |
1987-12-08 |
$55,077,000 |
